Section Arrow
CGEN.NASDAQ
- Compugen Ltd
Quotes are at least 15-min delayed:2026/06/02 12:11 EDT
Regular Hours
Last
 2.285
-0.175 (-7.11%)
Day High 
2.4306 
Prev. Close
2.46 
1-M High
3.05 
Volume 
493.87K 
Bid
2.28
Ask
2.29
Day Low
2.25 
Open
2.43 
1-M Low
2.43 
Market Cap 
232.68M 
Currency 美元 
P/E 5.93 
%Yield -- 
10-SMA 2.7 
20-SMA 2.76 
50-SMA 2.61 
52-W High 3.235 
52-W Low 1.295 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.38/-0.37
Enterprise Value
235.12M
Balance Sheet
Book Value Per Share
1.01
Cash Flow
Cash Flow Yield
0.14
Income Statement
Total Revenue
72.76M
Operating Revenue Per Share
0.77
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
EVGNEvogene Ltd.0.6127-0.0703-10.29%-- 
ADTXAditxt Inc.0.113------ 
FULCFulcrum Therapeutics2.97-3.45-53.74%-- 
AIMAIM ImmunoTech Inc.0.767-0.1316-14.65%-- 
ABVXAbivax SA71.595-58.095-44.80%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.